ACE launches Get Fit Site for consumers The American Council on Exercise.

Workout Routines: Free trial exercise programs from ACE include a warm-up, full workout and cool-down in addition to step-by-step workout demonstrations and guidance on frequency and intensity levels straight from ACE’s fitness professionals.Fitness Calculators/Tools: A series of interactive health and fitness calculators and equipment help both customers and fitness professionals properly tailor an exercise and fitness program to their needs, including equipment for determining your body mass index, focus on heartrate zone, daily caloric needs, physical activity requirements for weight loss and more.Workout and Fitness Reviews: As the nation’s workout watchdog, ACE conducts independent expert reviews that target fitness products, trends and applications to empower customers and fitness enthusiasts to create informed decisions.Health & Fitness Suggestions and Fit Specifics: ACE provides quick tips offering insight in to the latest research, research, trends and workout routines along with one-page info linens containing valuable how-to info and tips within an easy-to-read format.

Dr. Green prospects Ablexis as chief executive officer and brings 18 years of leadership in antibody discovery, therapeutic product development and collaborative research knowledge to the Ablexis group. Dr. Green was a founder of Abgenix, where he offered in a number of executive level analysis positions and led or contributed to more than 50 antibody discovery tasks. Dr. Green is joined by Hiroaki Shizuya, M.D., Ph.D., who serves simply because Ablexis’s resident advisor in molecular biology. As the creator of bacterial artificial chromosome technology, Dr. Shizuya contributes exclusive insights into molecular biology, DNA manipulation and genome characterization. Joining Dr. Green and Dr. Pfeffer on Ablexis’s table of directors is certainly Lou Tartaglia, Ph.D., partner at Third Rock Ventures.Dr. Green prospects Ablexis as chief executive officer and brings 18 years of leadership in antibody discovery, therapeutic product development and collaborative research knowledge to the Ablexis group. Dr. Green was a founder of Abgenix, where he offered in a number of executive level analysis positions and led or contributed to more than 50 antibody discovery tasks. Dr. Green is joined by Hiroaki Shizuya, M.D., Ph.D., who serves simply because Ablexis’s resident advisor in molecular biology. As the creator of bacterial artificial chromosome technology, Dr. Shizuya contributes exclusive insights into molecular biology, DNA manipulation and genome characterization. Joining Dr. Green and Dr. Pfeffer on Ablexis’s table of directors is certainly Lou Tartaglia, Ph.D., partner at Third Rock Ventures.